A comprehensive view of Abbott Laboratories. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
INTERNATIONAL PATENT: ABBOTT LABORATORIES FILES APPLICATION FOR "BIOMARKERS AND METHODS FOR DIFFERENTIATING BETWEEN MILD AND SUPERMILD TRAUMATIC BRAIN INJURY"
Published:
March 27, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: ABBOTT LABORATORIES FILES APPLICATION FOR "HBV DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC METHODS AND PRODUCTS"
Published:
March 27, 2024
by U.S. Fed News
|
U.S. Patent and Trademark Office Receives Abbott Diabetes Care's Patent Application for Systems and Methods for Updating a Medical Device
Published:
March 27, 2024
by Medical Patent News
|
Abbott Laboratories Climbs to No. 27 on Fortune's Most Innovative Companies List and Educates on Diabetes-Heart Disease Link, Reinforcing Its Industry Leadership
Published:
March 27, 2024
by Industry Intelligence Inc.
|
Abbott gets CE Mark approval for Bluetooth-enabled Assert-IQ insertable cardiac monitor in Europe; device offers the world's longest battery life and allows physicians to monitor patients' heart rhythms remotely for up to six years
Published:
March 25, 2024
by Abbott Laboratories
|
Ask us about our Government & Public Policy market view